To confirm our TAM and Treg cell transcriptional findings, we evaluated pretreatment tumour samples (n = 27) using multiplex immunofluorescence staining for pan-cytokeratin (tumour marker), FOXP3 (Treg cell marker), CD68 (macrophage marker) and PD-L1. The gene discussed is FOXP3; the disease is neoplasm.